Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Q Biomed Inc. stock logo
QBIO
Q Biomed
$0.00
$0.00
$0.03
N/AN/AN/AN/A
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Q Biomed Inc. stock logo
QBIO
Q Biomed
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Q Biomed Inc. stock logo
QBIO
Q Biomed
$0.00
$0.00
$0.03
N/AN/AN/AN/A
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Q Biomed Inc. stock logo
QBIO
Q Biomed
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Q Biomed Inc. stock logo
QBIO
Q Biomed
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/A-$0.02N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Q Biomed Inc. stock logo
QBIO
Q Biomed
N/A

Insider Ownership

CompanyInsider Ownership
Q Biomed Inc. stock logo
QBIO
Q Biomed
28.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Q Biomed Inc. stock logo
QBIO
Q Biomed
3N/AN/ANot Optionable

Recent News About These Companies

Q BioMed Inc
Orchestra Biomed Reports Q3 2024 Financial Results
A Powerful New Tool for Biomedical Research
Q BioMed Inc QBIO
Biomedical Sciences PhD Program

New MarketBeat Followers Over Time

Q Biomed stock logo

Q Biomed OTCMKTS:QBIO

Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.